In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...

Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

BUT BEFORE I LET YOU GO, ONE LAST QUESTION ABOUT VACCINE. AND THIS IS COVID. SO, YOU KNOW, WE’VE TALKED ABOUT THAT AT NAUSEUM FOR THE LAST, WHAT, FIVE YEARS. PROTECTION WANES OVER TIME.

The Wall Street Journal reported that the Food and Drug Administration had missed the deadline for making a key decision regarding a COVID-19 vaccine from Novavax, days after the vaccine chief ...

"If they don't approve Novavax, they put every COVID vaccine at risk," Jefferies analyst Roger Song said, adding that the Novavax vaccine works "as good as, if not better than other COVID vaccines".

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 ...